Skip to main content
SpringerLink
Log in

The JAK2V617F mutation: no impact on circulating hematopoietic progenitors in myeloproliferative disorders

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA Erber WN, Green AR (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054–61

    PubMed  CAS  Google Scholar 

  2. Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, Marchetti M, Frassoni F (2001) Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia. Blood 98:3249–55

    Article  PubMed  CAS  Google Scholar 

  3. Chervenick PA (1973) Increase in circulating stem cells in patients with myelofibrosis. Blood 41:67–71

    PubMed  CAS  Google Scholar 

  4. Oehler L, Foedinger M, Koeller M Kollars M, Reiter E, Bohle B, Skoupy S, Fritsch G, Lechner K, Geissler K (1997) Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogeneous granulocyte-macrophage colony-stimulating factor release. Blood 89:1147–53

    PubMed  CAS  Google Scholar 

  5. Sagaster V, Jäger E, Weltermann A, Schwarzinger I, Gisslinger H, Lechner K, Geissler K, Oehler L (2003) Circulating haematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia. Haematologica 88:1204–12

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine I, Division of Hematology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria

    Michaela Wappl, Raiko Kusec & Leopold Oehler

  2. Institute of Laboratory Medicine, University of Vienna, Vienna, Austria

    Eva Jaeger & Ilse Schwarzinger

  3. Fifth Medical Department—Oncology, Hospital Lainz, Vienna, Austria

    Klaus Geissler

Authors
  1. Michaela Wappl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eva Jaeger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raiko Kusec
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ilse Schwarzinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Klaus Geissler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leopold Oehler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leopold Oehler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wappl, M., Jaeger, E., Kusec, R. et al. The JAK2V617F mutation: no impact on circulating hematopoietic progenitors in myeloproliferative disorders. Ann Hematol 87, 509–511 (2008). https://doi.org/10.1007/s00277-007-0428-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-007-0428-x

Keywords

Search

Navigation